Artelo Biosciences Inc. (ARTL)
NASDAQ: ARTL
· Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT
Artelo Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Net Income | -3.99M | -2.37M | -3.78M | -2.28M | -2.43M | -2.48M | -3.07M | -2.45M | -1.6M | -2.17M | -3.34M | -2.33M | -2.45M | -1.97M | -2.55M | -1.89M | -2.25M | -1.87M |
Depreciation & Amortization | 54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 61.00 | 62.00 |
Stock-Based Compensation | 117K | 192K | 201K | 38K | 195K | 213K | 219K | 222K | 225K | 354K | 608K | 607K | 619K | 624K | 571K | 519.83K | 618.36K | 341.45K |
Other Working Capital | -169K | -187K | -61K | 470K | 29.00 | 5K | 73K | 256K | 169K | -68K | -4K | 139K | 264K | -594K | -80K | n/a | -150.55K | 25.7K |
Other Non-Cash Items | 3.27M | 770K | -33K | 914.57K | 2.24M | -106K | -165K | -165K | -187K | -124K | -137K | -70K | -23K | 19K | -1K | 6.82K | 1.33K | -1.33K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 62K | -187K | 1.04M | 470K | 29.00 | -566K | 423K | 590K | -62K | -248K | 575K | 97K | -113K | -731K | 52K | -181.31K | -150.55K | 25.7K |
Operating Cash Flow | -488K | -1.6M | -2.57M | -858.43K | -2.06K | -2.94M | -2.6M | -1.8M | -1.62M | -2.19M | -2.29M | -1.7M | -1.97M | -2.05M | -1.93M | -1.54M | -1.78M | -1.5M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 2.35M | n/a | n/a | 8.15M | 1.92K | -481K | -949K | -4.58M | -2.35M | -5.8M | -2.18M | -7.86M | -740K | -2.45M | -10.76M | n/a | n/a | n/a |
Sales Maturities Of Investments | -2.75M | n/a | 500K | -3M | n/a | 1.75M | 3.69M | 2.75M | 2.75M | 8M | 3.98M | 4.78M | 4.72M | 2.7M | 1.88M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -813.98K | -172 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.44M | 510.69K | n/a |
Investing Cash Flow | -399K | n/a | 500K | 4.34M | 1.75K | 1.27M | 2.74M | -1.83M | 399K | 2.2M | 1.8M | -3.08M | 3.98M | 257K | -8.88M | -3.44M | 510.69K | -510.69K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.07M | n/a | n/a | n/a | 219.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.11M | 593.36K | 5.32M |
Financial Cash Flow | 3.07M | n/a | 57K | 794.50 | n/a | 55K | 32K | 535K | -1.25M | n/a | 134K | n/a | -134K | n/a | 18.26M | 1.6M | 617.48K | 5.32M |
Net Cash Flow | -3.65M | -1.59M | -2.02M | 3.48M | -314 | -1.62M | 176K | -3.08M | -1.2M | 28K | -248K | -4.99M | 1.77M | -1.81M | 7.42M | -3.42M | -654.14K | 3.32M |
Free Cash Flow | -488K | -1.6M | -2.57M | -1.97M | -2.06K | -2.94M | -2.6M | -1.8M | -1.62M | -2.19M | -2.29M | -1.7M | -1.97M | -2.05M | -1.93M | -1.54M | -1.78M | -1.5M |